We have expert spokespeople available to comment on everything from healthcare, research and policy issues in the current news agenda, to talking about myeloma and how it affects patients.
Our key spokespeople are below, but if you have a specific enquiry please do get in touch.
Judy Dewinter, Chairman and myeloma patient
Key areas of interest: Judy can provide insight into living with myeloma, and the importance of the discovery and development of new treatments for myeloma patients.
She has been Chairman of the Myeloma UK Board of Directors since 2006. As a passionate patient advocate, Judy speaks at national and international meetings and participates on various advisory boards. She also prioritises time to speak to patients and their families, knowing from personal experience the difficulty of living and coping with myeloma.
Follow Judy on Twitter: @JudyDewinter
Rosemarie Finley, Chief Executive
Key areas of interest: Rosemarie has more than 30 years of experience in the healthcare sector, balancing strategic vision and operational know how. She can provide insight into the understanding of and response to myeloma patients’ treatment and care.
Rosemarie joined Myeloma UK in June 2017 as Chief Executive. She is an energetic and innovative leader with more than 30 years of experience in the healthcare sector. She is a registered nurse and health visitor and has held a number of senior leadership positions within NHS trusts, the charitable sector and within healthcare publishing, including Director of Education, Research and Development, Associate Chief Nurse, Associate Director of Operations and Publishing Director. Rosemarie was Chief Operations Officer at the Epilepsy Society and also worked with them as their interim Chief Executive Officer immediately prior to joining Myeloma UK. Rosemarie combines her strong commitment to patients and the health and research agenda with a clear understanding of our overall healthcare systems.
Follow Rosemarie on Twitter: @MyelomaUKCEO
Dr Simon Ridley, Director of Research
Key areas of interest: Simon has a background in biomedical research. He can provide expert opinion and insight into myeloma research including the discovery and development of new treatments, and the organisation’s health services research programme which is focused on better understanding the needs and experiences of people affected by myeloma.
Simon directs the research strategy at Myeloma UK. Working closely with Myeloma UK research partners and an independent Research Advisory Group comprising expert peer and patient input, he ensures that Myeloma UK addresses its long-term vision of finding a cure for myeloma, as well as current patient need. Simon has previously worked across the research charity, biotech and academic sectors, including at Alzheimer’s Research UK and the University of Cambridge. He has experience of working on research strategy and funding, including national and international partnership programmes with academia, government funders and industry.
Barbara Osborne, Director of Income Generation
Key areas of interest: Barbara has over 20 years of experience working for high profile charities, and is an Executive Committee Member of the Institute of Fundraising, Scotland. She can provide insight and comment on all areas of improving income generation from community fundraising and individual giving, to securing funding from trusts and foundations.
Barbara is part of the Executive Leadership Team at Myeloma UK and is responsible for the income generation strategy. She has a great deal of experience in delivering results driven fundraising and has previously worked for the British Heart Foundation (BHF) and the Children’s Hospice Association Scotland (CHAS).